{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:49:59Z","timestamp":1792428599326,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jpurol.2011.07.014","type":"journal-article","created":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T09:20:51Z","timestamp":1315819251000},"page":"386-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: Results of a prospective long-term study"],"prefix":"10.1016","volume":"8","author":[{"given":"Heinrich","family":"Schulte-Baukloh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"M\u00fcrtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Strugala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut H.","family":"Knispel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2011.07.014_bib1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-5347(01)65238-8","article-title":"Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population","volume":"157","author":"Palmer","year":"1997","journal-title":"J Urol"},{"issue":"Suppl. 1","key":"10.1016\/j.jpurol.2011.07.014_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1464-410X.92.s1.2.x","article-title":"The management of the myelodysplastic child: a paradigm shift","volume":"92","author":"Bauer","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2011.07.014_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000472508","article-title":"Oxybutinin and the prevention of urinary incontinence in spina bifida","volume":"11","author":"Hehir","year":"1985","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2011.07.014_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0090-4295(97)00489-5","article-title":"Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia","volume":"51","author":"Goessl","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2011.07.014_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1254\/jjp.87.27","article-title":"Effects of antimuscarinic drugs on both urinary frequency and cognitive impairment in conscious, nonrestrained rats","volume":"87","author":"Oka","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.jpurol.2011.07.014_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/00912700122010528","article-title":"Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system","volume":"41","author":"Todorova","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jpurol.2011.07.014_bib7","first-page":"1053","article-title":"Complications of clean intermittent catheterization in young females with myelomeningocele: 10 \u2013 19 years of followup","volume":"178","author":"Lindehall","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jpurol.2011.07.014_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1464-410x.2001.02152.x","article-title":"Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida","volume":"87","author":"Ferrara","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2011.07.014_bib9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s003450100223","article-title":"Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic)","volume":"19","author":"Madersbacher","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.jpurol.2011.07.014_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.eururo.2006.03.016","article-title":"Propiverine compared to oxybutynin in neurogenic detrusor overactivity \u2013 Results of a randomized, double-blind, multicenter, clinical study","volume":"52","author":"St\u00f6hrer","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2011.07.014_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1464-410X.2006.05953.x","article-title":"Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis","volume":"97","author":"Schulte-Baukloh","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2011.07.014_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1464-410X.2008.08093.x","article-title":"Propiverine versus oxybutynin treatment in neurogenic detrusor overactivity of children and adolescents: results of a multicentre observational cohort study","volume":"103","author":"Madersbacher","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2011.07.014_bib13","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.eururo.2006.02.026","article-title":"Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity \u2013 a retrospective study","volume":"49","author":"Grigoleit","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2011.07.014_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-4295(01)01641-7","article-title":"Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results","volume":"59","author":"Schulte-Baukloh","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2011.07.014_bib15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF02012459","article-title":"Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology","volume":"23","author":"Fernbach","year":"1993","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jpurol.2011.07.014_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"issue":"3 Pt 2","key":"10.1016\/j.jpurol.2011.07.014_bib17","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0022-5347(01)64448-3","article-title":"Age related bladder capacity and bladder capacity growth in children with myelomeningocele","volume":"158","author":"Palmer","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2011.07.014_bib18","first-page":"205","article-title":"Prognostic value of urodynamic testing in myelodysplastic patients","volume":"126","author":"McGuire","year":"1981","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jpurol.2011.07.014_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000102915","article-title":"Long-term efficacy of tolterodine and patient compliance in pediatric patients with neurogenic detrusor overactivity","volume":"79","author":"Christoph","year":"2007","journal-title":"Urol Int"},{"key":"10.1016\/j.jpurol.2011.07.014_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1464-410X.2009.09129.x","article-title":"Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urinary incontinence due to overactive bladder: results of a multicentre observational cohort study","volume":"106","author":"Alloussi","year":"2009","journal-title":"BJU Int"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513111002051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513111002051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:37:24Z","timestamp":1761485844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513111002051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1477513111002051"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2011.07.014","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: Results of a prospective long-term study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2011.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}